Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INtensive Cholesterol-Lowering With recatIcimab combiNation in Emergency PCI for Acute Myocardial Infarction: A Randomized Controlled Trial

NCT07290699 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT07290699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07290699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INtensive Cholesterol-Lowering With recatIcimab combiNation in Emergency PCI for Acute Myocardial Infarction: A Randomized Controlled Trial
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
August 30, 2028
Enrollment
2,442 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nstemi - non-st segment elevation myocardial infarction (mi), stemi - st elevation myocardial infarction